Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies.
[embedded content] TDR Top 3 takeaways from the video on MindMed’s announcements, and plans for 2025: MindMed achieved a significant milestone in 2024 by dosing
NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has received notice from the Nasdaq Hearings
NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company“) today announced that it has entered into definitive agreements for the
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the
When making decisions about nutrition and diet, the focus is often on the potential impacts to the heart or brain; and gut health can frequently
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. How lawmakers view UnitedHealth Group
When leaders of Florida’s most populous county met in September to pick a site for what could become the nation’s largest trash incinerator, so many
Maurice Clark huddled in his tent along dusty railroad tracks as two homeless-outreach workers began asking him questions to determine whether he would qualify for
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! This is our